Latest filing published 01 Sept 2020 for Cell MedX Corp, €6,276.
No signal scores available.
Frank Edward McEnulty appears in our data through filings on Cell MedX Corp shares, published by SEDI. We count 3 filings; the first trade dates from 1 June 2020 and the latest from 30 July 2020.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 1 September 2020, reports a transaction of €6,276 in Cell MedX Corp. Filings reach the SEDI feed a median of 33 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations